Search alternatives:
significant group » significant gap (Expand Search), significant amount (Expand Search)
mean decrease » a decrease (Expand Search)
group based » groups based (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 61 - 80 results of 89,885 for search '(( significant group based ) OR ( significant ((we decrease) OR (mean decrease)) ))', query time: 1.28s Refine Results
  1. 61
    Absorption peaks of groups.

    Absorption peaks of groups. by Xinhui Luo (11880086)

    Published 2025
    “…Finally, considering all monomer surfactants’ abilities to reduce surface tension, decrease contact angles and promote dust settling in solutions, we selected five surfactants (AES, MES-30, AEO-9, CDEA and CHSB) for blending based on their excellent performance in tests. …”
    Save to List
    Saved in:
  2. 62
    Baseline patient characteristics.

    Baseline patient characteristics. by Oscar F. C. van den Bosch (22184246)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Bacterial groups that significantly changed over time within the control group based on qPCR analysis.

    Bacterial groups that significantly changed over time within the control group based on qPCR analysis. by Evangelia M. Stavroulaki (11840809)

    Published 2021
    Save to List
    Saved in:
  4. 64
    The significant metabolites between adjacent groups.

    The significant metabolites between adjacent groups. by Zhonglong Zhao (1546420)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Prisma flow diagram of this meta-analysis.

    Prisma flow diagram of this meta-analysis. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 76
    Forest plot for O<sub>2</sub> desaturation in THRIVE versus FMV after intubation.

    Forest plot for O<sub>2</sub> desaturation in THRIVE versus FMV after intubation. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 77
    Risk of bias assessment.

    Risk of bias assessment. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 78
    Forest plot for safe apnoea time in THRIVE versus FMV after intubation.

    Forest plot for safe apnoea time in THRIVE versus FMV after intubation. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 79
    Basic characteristics of included studies.

    Basic characteristics of included studies. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 80
    Forest plot for PaO<sub>2</sub> in THRIVE versus FMV after intubation.

    Forest plot for PaO<sub>2</sub> in THRIVE versus FMV after intubation. by Delai Zheng (18468980)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: